Page 92 - MDAnderson Memoria 2017

92
• Mota A, Colás E, García-Sanz P, Campoy I, Rojo-Sebastián A, Gatius S, García Á, Chiva L, Alonso S, Gil-Moreno A, González-Tallada X, Díaz-Feijoo B, Vidal A, Ziober-Malinowska P, Bobiński M, López-López R, Abal M, Reventós J, Matias-Guiu X, Moreno-Bueno G. Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers. Mod Pathol. 2017 Jan;30(1):134-145. doi: 10.1038/ modpathol.2016.143. PMID: 27586201.
• Salvador F, Martin A, López-Menéndez C, Moreno-Bueno G, Santos V, Vázquez-Naharro A, Santamaria PG, Morales S, Dubus PR, Muinelo-Romay L, López-López R, Tung JC, Weaver VM, Portillo F, Cano A. Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer. Cancer research. 2017; 77(21):5846-5859. NIHMSID: EMS73430. PMID: 28720577 PMCID: PMC5656180
• Rodríguez-Ubreva J, Català-Moll F, Obermajer N, Álvarez-Errico D, Ramirez RN, Company C, Vento-Tormo R, Moreno-Bueno G, Edwards RP, Mortazavi A, Kalinski P, Ballestar E. Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells. Cell reports. 2017; 21(1):154-167. PMID: 28978469
HEMATOLOGÍA / HEMATOLOGY
• Montalbán C, Díaz-López A, Dlouhy I, Rovira J, López-Guillermo A, Alonso S, Martín A, Sancho JM, García O, Sánchez JM, Rodríguez M, Novelli S, Salar A, Gutiérrez A, Rodríguez-Salazar MJ, Bastos M, Domínguez JF, Fernández R, González de Villambrosia S, Queizan JA, Córdoba R, de Oña R, López-Hernandez A, Freue JM, Garrote H, López L, Martín-Moreno AM, Rodríguez J, Abraira V, García JF; GELTAMO-IPI Project Investigators.. Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2 -microglobulin yields a more accurate GELTAMO-IPI. Br J Haematol. 2017 Mar;176(6):918-928. doi: 10.1111/bjh.14489. 2017 Jan 20. PMID: 28106247.
• Guisado-Vasco P, Montalbán C, García JF. Comments on the value International Prognostic Score (IPS), stage IV and age over 45 years, for the outcome of advanced Hodgkin lymphoma in chemotherapy containing adriamycin. The experience of the Spanish Hodgkin Lymphoma Study Group. British journal of haematology. 2017; 178(2):336-338. PMID: 27135208
• Salar A, Domingo-Domenech E, Panizo C, Nicolás C, Bargay J, Muntañola A, Canales M, Bello JL, Sancho JM, Tomás JF, Rodríguez MJ, Peñalver J, Grande C, Sánchez-Blanco JJ, Palomera L, Arranz R, Conde E, García M, García JF, Caballero D, Montalbán C. Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma. Blood. 2017; 130(15):1772-1774. PMID: 28801448
• Matutes E, Montalbán C. Clinical features and management of non-gastrointestinal non-ocular extranodal mucosa associated lymphoid tissue (ENMALT) marginal zone lymphomas. Best Pract Res Clin Haematol. 2017 Mar - Jun;30(1-2):99-108. doi: 10.1016/j.beha.2016.07.005. 2016 Nov 5. Review. PMID: 28288723.
• Peñalver FJ, Sancho JM, de la Fuente A, Olave MT, Martín A, Panizo C, Pérez E, Salar A, Orfao A; Spanish Lymphoma Group (GELTAMO). Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO). Haematologica. 2017 Feb;102(2):235-245. doi: 10.3324/haematol.2016.149120. 2016 Oct 20. PMID: 27846613; PMCID: PMC5286932.
ONCOLOGÍA MÉDICA / MEDICAL ONCOLOGY
• González Martín A. Progress in PARP inhibitors beyond BRCA mutant recurrent ovarian cancer? Lancet Oncol. 2017 Jan;18(1):8-9. doi: 10.1016/S1470-2045(16)30621-0. 2016 Nov 29. PMID: 27908593.
• Oza AM, Selle F, Davidenko I, Korach J, Mendiola C, Pautier P, Chmielowska E, Bamias A, DeCensi A, Zvirbule Z, González-Martín A, Hegg R, Joly F, Zamagni C, Gadducci A, Martín N, Robb S, Colombo N. Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study. Int J Gynecol Cancer. 2017 Jan;27(1):50-58. doi: 10.1097/IGC.0000000000000836. PMID: 27749456; PMCID: PMC5181120.
• De Castro J, González-Larriba JL, Vázquez S, Massutí B, Sánchez-Torres JM, Dómine M, Garrido P, Calles A, Artal A, Collado R, García R, Sereno M, Majem M, Macías JA, Juan O, Gómez-Codina J, Hernández B, Lázaro M, Ortega AL, Cobo M, Trigo JM, Carcereny E, Rolfo C, Macia S, Muñoz J, Diz P, Méndez M, Rosillo F, Paz-Ares L, Cardona JV, Isla D. Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy. Clin Transl Oncol. 2017 Feb;19(2):219-226. doi: 10.1007/s12094-016-1527-8. 2016 Jul 1. PMID: 27371031.
GINECOLOGÍA ONCOLÓGICA
ONCOLOGIC GYNECOLOGY
• Harter P, Reuss A, Sehouli J, Chiva L, du Bois A. Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al. Int J Gynecol Cancer. 2017 Feb;27(2):246-247. doi: 10.1097/ IGC.0000000000000864. PMID: 28114231.
• Pimentel I, González Martín A, Bratos R, Márquez R, Toledo G, Chiva L. Advanced stage yolk sac ovarian tumour: clinical approach with cytoreductive surgery upfront. Eur J Gynaecol Oncol. 2017; 38(2):311-313. PMID: 29953803.